• 178 Citations
  • 7 h-Index
20092020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

  • 178 Citations
  • 7 h-Index
  • 24 Article
  • 3 Review article
  • 1 Comment/debate
  • 1 Letter
Filter
Article
2020

Stenting in non-small cell lung cancer: How does it affect the outcomes?

Karim, N. A., Khaddam, S., Shehata, M., Mostafa, A., Magdy, M., Eldessouki, I., Xie, C. & Benzaquen, S., Jan 1 2020, In : Asian Pacific Journal of Cancer Prevention. 21, 1, p. 175-178 4 p.

Research output: Contribution to journalArticle

Open Access
2019
Open Access

Impact of tricyclic antidepressants, selective serotonin reuptake inhibitors, and other antidepressants on overall survival of patients with advanced lung cancer from 2004 to 2014: University of Cincinnati experience

Abdel Karim, N. F., Hassan, R., Siddiqi, N. I., Eldessouki, I., Gaber, O., Rahouma, M., Kamel, M., Yellu, M., Gulati, S., Xie, C., Magdy, M. & Pruemer, J., Dec 1 2019, In : Journal of International Medical Research. 47, 12, p. 6016-6026 11 p.

Research output: Contribution to journalArticle

Open Access
1 Scopus citations

Pneumonitis as a complication of immune system targeting drugs?—a meta-analysis of anti-PD/PD-L1 immunotherapy randomized clinical trials

Rahouma, M., Baudo, M., Yahia, M., Kamel, M., Gray, K. D., Elmously, A., Ghaly, G., Eldessouki, I., Abouarab, A., Cheriat, A. N., Karim, N. A., Mohamed, A., Morris, J. & Gaudino, M., Jan 1 2019, In : Journal of Thoracic Disease. 11, 2, p. 521-534 14 p.

Research output: Contribution to journalArticle

7 Scopus citations

Retrospective study of the effect of statins on the outcome of lung cancer patients, University of Cincinnati experience

Gaber, O., Eldessouki, I., Hassan, R., Magdy, M., Morris, J. C. & Karim, N. A., Jan 1 2019, In : Asian Pacific Journal of Cancer Prevention. 20, 8, p. 2391-2396 6 p.

Research output: Contribution to journalArticle

Open Access

Role of Targeted Therapy and Immune Checkpoint Blockers in Advanced Non-Small Cell Lung Cancer: A Review

Abdel Karim, N. & Kelly, K., Sep 1 2019, In : Oncologist. 24, 9, p. 1270-1284 15 p.

Research output: Contribution to journalArticle

4 Scopus citations
2018

nab-paclitaxel-based therapy in underserved patient populations: The ABOUND.PS2 study in patients with NSCLC and a performance status of 2

Gajra, A., Karim, N. A., Mulford, D. A., Villaruz, L. C., Matrana, M. R., Ali, H. Y., Santos, E. S., Berry, T., Ong, T. J., Sanford, A., Amiri, K. & Spigel, D. R., Jul 24 2018, In : Frontiers in Oncology. 8, JUL, 253.

Research output: Contribution to journalArticle

Open Access
4 Scopus citations

Pulmonary sarcomatoid carcinoma: University of Cincinnati experience

Karim, N. A., Schuster, J., Eldessouki, I., Gaber, O., Namad, T., Wang, J., Xie, C. & Morris, J. C., Jan 1 2018, In : Oncotarget. 9, 3, p. 4102-4108 7 p.

Research output: Contribution to journalArticle

Open Access
9 Scopus citations

Small or non-small cell lung cancer based therapy for treatment of large cell neuroendocrine cancer of the lung? University of Cincinnati experience

Eldessouki, I., Gaber, O., Namad, T., Wang, J., Morris, J. C. & Karim, N. A., Jan 1 2018, In : Journal of Oncology. 2018, 9761826.

Research output: Contribution to journalArticle

Open Access
3 Scopus citations
2017

A case study in advanced lung cancer patients with vimentin over expression

Karim, N. A., Eldessouki, I., Yellu, M., Namad, T., Wang, J. & Gaber, O., Jan 1 2017, In : Clinical Laboratory. 63, 10, p. 1575-1579 5 p.

Research output: Contribution to journalArticle

9 Scopus citations

A Phase Ib Study of the Dual PI3K/mTOR Inhibitor Dactolisib (BEZ235) Combined with Everolimus in Patients with Advanced Solid Malignancies

Wise-Draper, T. M., Moorthy, G., Salkeni, M. A., Karim, N. A., Thomas, H. E., Mercer, C. A., Beg, M. S., O’Gara, S., Olowokure, O., Fathallah, H., Kozma, S. C., Thomas, G., Rixe, O., Desai, P. & Morris, J. C., Jun 1 2017, In : Targeted Oncology. 12, 3, p. 323-332 10 p.

Research output: Contribution to journalArticle

Open Access
29 Scopus citations

Frontline systemic therapy with pemetrexed-platinum in nonsquamous non-small-cell lung cancer with asymptomatic brain metastases

Alsidawi, S., Chaudhary, R. & Karim, N. A., Jan 1 2017, In : American journal of therapeutics. 24, 2, p. e111-e120

Research output: Contribution to journalArticle

1 Scopus citations

Intracranial Germinoma: Systemic Chemotherapy in Addition to Dose-Reduced Radiation Therapy

Chiec, L., Curry, R. & Karim, N. A., Jan 1 2017, In : American journal of therapeutics. 24, 5, p. e609-e610

Research output: Contribution to journalArticle

Pulmonary Sarcomatoid Carcinomas Commonly Harbor Either Potentially Targetable Genomic Alterations or High Tumor Mutational Burden as Observed by Comprehensive Genomic Profiling

Schrock, A. B., Li, S. D., Frampton, G. M., Suh, J., Braun, E., Mehra, R., Buck, S. C., Bufill, J. A., Peled, N., Karim, N. A., Hsieh, K. C., Doria, M., Knost, J., Chen, R., Ou, S. H. I., Ross, J. S., Stephens, P. J., Fishkin, P., Miller, V. A., Ali, S. M. & 2 others, Halmos, B. & Liu, J. J., Jun 2017, In : Journal of Thoracic Oncology. 12, 6, p. 932-942 11 p.

Research output: Contribution to journalArticle

Open Access
48 Scopus citations
2016

Lung sarcomatoid carcinoma (LSC) harbors targetable genomic alterations and high mutational burden as observed by comprehensive genomic profiling (CGP)

Halmos, B., Frampton, G. M., Suh, J., Braun, E., Mehra, R., Buck, S., Bufill, J. A., Peled, N., Karim, N. A., Fishkin, P., Knost, J., Ou, S. H. I., Ross, J. S., Stephens, P. J., Miller, V. A., Ali, S. M. & Schrock, A. B., Oct 1 2016, In : Annals of Oncology. 27, p. vi419

Research output: Contribution to journalArticle

Open Access

Ocular adnexal lymphoma presenting with visual loss

Gulati, S., Corrêa, Z. M., Karim, N. & Medlin, S., Jan 2016, In : North American Journal of Medical Sciences. 8, 1, p. 56-60 5 p.

Research output: Contribution to journalArticle

1 Scopus citations
2015

Diabetes insipidus: An unusual presentation of adenocarcinoma of the lung in a patient with no identifiable lung mass

Gulati, S., Kiefer, C. & Karim, N. A., Oct 30 2015, In : North American Journal of Medical Sciences. 7, 10, p. 476-479 4 p.

Research output: Contribution to journalArticle

1 Scopus citations
2014

Hepatic epithelioid hemangioendothelioma in a patient with hemochromatosis

Ahmad, N., Adams, D. M., Wang, J., Prakash, R. & Karim, N. A., Sep 1 2014, In : JNCCN Journal of the National Comprehensive Cancer Network. 12, 9, p. 1203-1207 5 p.

Research output: Contribution to journalArticle

Open Access
6 Scopus citations

Influenza vaccination in cancer patients undergoing systemic therapy

Shehata, M. A. & Karim, N. A., May 1 2014, In : Clinical Medicine Insights: Oncology. 8, p. 57-64 8 p.

Research output: Contribution to journalArticle

20 Scopus citations

Phase II clinical trial of gefitinib for the treatment of chemonaïve patients with advanced non-small cell lung cancer with poor performance status

Karim, N. A., Musaad, S., Zarzour, A., Patil, S. & Jazieh, A. R., Nov 25 2014, In : Clinical Medicine Insights: Oncology. 8, p. 121-128 8 p.

Research output: Contribution to journalArticle

Open Access
3 Scopus citations

The use of pharmacogenomics for selection of therapy in Non-Small-Cell lung cancer

Karim, N. A., Bui, H., Pathrose, P., Starnes, S., Patil, N., Shehata, M., Mostafa, A., Rao, M. B., Zarzour, A. & Anderson, M., Jan 1 2014, In : Clinical Medicine Insights: Oncology. 8, p. 139-144 6 p.

Research output: Contribution to journalArticle

Open Access
2 Scopus citations
2013

A phase II study of modulated-capecitabine and docetaxel in chemonaive patients with advanced non-small cell lung cancer (NSCLC)

Bertino, E. M., Bekaii-Saab, T., Fernandez, S., Diasio, R. B., Karim, N. A., Otterson, G. A. & Villalona-Calero, M. A., Jan 1 2013, In : Lung Cancer. 79, 1, p. 27-32 6 p.

Research output: Contribution to journalArticle

3 Scopus citations

Approach to management of thrombotic thrombocytopenic Purpura at University of Cincinnati

Abdel Karim, N., Haider, S., Siegrist, C., Ahmad, N., Zarzour, A., Ying, J., Yasin, Z. & Sacher, R., Dec 1 2013, In : Advances in Hematology. 2013, 195746.

Research output: Contribution to journalArticle

3 Scopus citations
2009

Phase II trial of thalidomide, irinotecan and gemcitabine in chemonaive patients with advanced non-small cell lung cancer

Jazieh, A. R., Komrokji, R., Gupta, A., Patil, S., Flora, D., Knapp, M., Issa, M. & Abdel Karim, N. F. M., Oct 22 2009, In : Cancer Investigation. 27, 9, p. 932-936 5 p.

Research output: Contribution to journalArticle

9 Scopus citations